Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation

NCT06528262 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Enavogliflozin
DRUG: Placebo

Sponsor

Yonsei University